1[1]Sleisenger & Fordtran's Gastrointestinal and Liver Disease 6th edition[M].北京:科学出版社,2001.
2[3]Zetterquist H,Broome U,Einarsson K,et al.HLA class II genes in primary sclerosing cholangitis and chronic inflammatory bowel disease:no HLA-DRw52a association in Swedish patients with sclerosing cholangitis[J].Gut,1992,33(7):942-946.
3[4]Donaldson PT,Farrant JM,Wilkinson ML,et al.Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis[J].Hepatology,1991,13 (1):129-133.
4[5]Mehal WZ,Lo YM,Wordsworth BP,et al.HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis[J].Gastroenterology,1994,106 (1):160-167.
5[6]Mitchell SA,Grove J,Spurkland A,et al.Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis[J].Gut,2001,49(2):288-294.
6[7]Satsangi J,Chapman RW,Haldar N,et al.A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis[J].Gastroenterology,2001,121 (1):124-130.
7[8]Norris S,Kondeatis E,Collins R,et al.Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis:the role of MICA pol-ymorphism[J].Gastroenterology,2001,120 (6):1475-1482.
8[9]Sheth S,Shea JC,Bishop MD,et al.Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cho-langitis[J].Hum Genet,2003,113 (3):286-292.
9[10]Cruickshank SM,Southgate J,Wyatt JI,et al.Expression of CD44 on bile ducts in primary sclerosing cholangitis and primary biliary cirrhosis[J].J Clin Pathol,1999,52(10):730-734.
10[11]Eksteen B,Miles AE,Grant AJ,et al.Lymphocyte homing in the pathogenesis of extra-intestinal manifestations of inflammatory bowel disease[J].Clin Med,2004,4(2):173-180.
